Newer systemic antifungal drugs for the treatment of onychomycosis

MM Chiritescu, MES Chiritescu, RK Scher - Clinics in podiatric medicine …, 1996 - Elsevier
Onychomycosis is a fungal disease of the nail caused by dermatophytes, yeasts, and
moulds; it is often considered incorrectly synonymous with tinea unguium, which is defined …

Antifungal combination treatment: a future perspective

C Fohrer, L Fornecker, Y Nivoix, C Cornila… - International journal of …, 2006 - Elsevier
The use of antifungal combination therapy is a new clinical approach for combating fungal
infections. Although few conclusive clinical studies have been performed to date, data exist …

The future of antifungal therapy

JR Graybill - Clinical Infectious Diseases, 1996 - academic.oup.com
In the late 1970s the options for systemic antifungal therapy doubled with the addition of
intravenous miconazole and oral ketoconazole to the two previously available agents …

Antifungal combinations

RG Vitale, J Afeltra, E Dannaoui - Antifungal agents: Methods and …, 2005 - Springer
The increase in fungal infections and the change in fungal epidemiology is caused by the
extensive use of antifungal agents to treat fungal infections that are being diagnosed in …

Onychomycosis: classification and diagnosis.

AK Gupta, JE Ryder, RC Summerbell - Journal of drugs in …, 2004 - europepmc.org
Onychomycosis is a common infection of the nail predominantly caused by anthropophilic
dermatophytes, and to a lesser extent by yeasts (Candida species) and non-dermatophyte …

The future of onychomycosis therapy may involve a combination of approaches

RJ Hay - British Journal of Dermatology, 2001 - academic.oup.com
Onychomycosis is a fungal infection of the nail unit, most commonly caused by the
anthropophilic dermatophyte fungi. It is generally accepted that this disease is increasing in …

Antifungal therapy: potential interactions with other classes of drugs

DR Bickers - Journal of the American Academy of Dermatology, 1994 - Elsevier
Combination drug therapy is widely used for the management of many common medical
conditions. The concurrent use of more than one drug can significantly alter the therapeutic …

Antifungal drugs: what brings the future?

R Van Daele, I Spriet, J Wauters, J Maertens… - Medical …, 2019 - academic.oup.com
The high burden and growing prevalence of invasive fungal infections (IFIs), the toxicity and
interactions associated with current antifungal drugs, as well as the increasing resistance …

Treatment failures and relapses in onychomycosis: a stubborn clinical problem

JE Arrese, GE Piérard - Dermatology, 2003 - karger.com
The therapeutic outcome of onychomycoses is uncertain. Comparative short-term efficacy
studies on antifungals abound and report contradictory findings. Few unbiased follow-up …

[图书][B] Ketoconazole in the management of fungal disease.

HB Levine - 1982 - cabidigitallibrary.org
The first section of this handbook, on Mycoses and Antimycotics, includes contributions by:
Hay, RJ Superficial and deep mycoses: the extent of the problem (The mycoses are …